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Introduction: There is no valid and reliable diagnostic test for early diagnosis of acute mesenteric ischemia
(AMI). The aim of this study was to measure the plasma levels of diamine oxidase (DAO) and citrulline in
AMI to gain insight into its early diagnosis.
Material and methods: A total of 21 Wistar albino rats were divided into three groups, that is, control group,
short-term ischemia group, and prolonged ischemia group. The superior mesenteric artery was occluded for
15 min in the short-term ischemia group and for 12 h in the prolonged ischemia group. Twelve hours later, the
experiment was terminated and plasma DAO and citrulline levels were measured. Intestinal tissue was
evaluated for the histopathological changes.
Results: Compared to the control group, the short-term and prolonged ischemia groups showed significant
increases in the plasma levels of DAO, whereas the plasma citrulline levels decreased significantly. Prolonged
ischemia caused a larger increase in the plasma DAO levels and a larger decrease in the plasma citrulline levels
compared to the short-term ischemia (p0.011 and p0.021, respectively). Intestinal damage was shown to
develop more in the prolonged ischemia group (p0.001).
Conclusion: In the early period of AMI, the plasma DAO levels increase while citrulline levels decrease, and
the extent of these changes depends on the duration of ischemia.
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A
cute mesenteric ischemia (AMI) is a serious
pathology that causes acute abdomen and is
life-threatening. AMI mostly occurs in the elderly
or in patients with cardiac problems (13). Its incidence
is higher than 10 in 100,000 (4). Despite the recent
improvements in diagnostic and therapeutic methods and
postoperative intensive care practices, the morbidity and
mortality associated with AMI remain quite high (2, 3).
Among many factors that affect AMI management, the
most important is early diagnosis and early revascular-
ization (5). For this reason, early diagnosis of AMI is
of great importance. Various methods have been studied
for the early diagnosis of AMI, but no diagnostic test
has been proven to be reliable with high sensitivity and
specificity (610).
Diamine oxidase (DAO) is an enzyme that catalyzes
oxidative deamination of histamine-like diamines. It is
mainly produced in the small intestine, where it is found
in high amounts (1113). It is reported that DAO levels in
plasma increase in cases of intestinal ischemia, inflam-
mation, and similar stresses (1416). Citrulline is an
amino acid that is produced mainly in enterocytes from
glutamate (17). The plasma citrulline level decreases in
various cases when intestinal capacity and mucosal
barriers are damaged (1820). The aim of this study
was to measure the plasma DAO and citrulline levels in
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the early period of AMI and to evaluate the utility of this
information as a potential marker for the early diagnosis
of AMI.
Material and methods
The present study was conducted in an Experimental
Research Center with the permission of University
Local Ethics Committee of Research on Experimental
Animals (2010/25). A total of 21 female Wistar albino
rats weighing 250300 g were used in this experiment.
All of the animals were housed and fed under physiolo-
gical conditions in accordance with the international
regulations and guidelines. Rats were randomly assigned
to three groups with seven rats in each. The control
group, the short-term ischemia group, and the prolonged
ischemia group were formed randomly, assigning seven
rats to each group. For general anesthesia, 50 mg/kg
ketamine and 10 mg/kg xylazine were injected intramus-
cularly. Surgical interventions were performed under
standard sterile conditions through a midline incision.
Control group
The surgical procedure was terminated after exploration
of the superior mesenteric artery.
Short-term ischemia group
The superior mesenteric artery was explored and
occluded by a Bulldog Clamp for 15 min. At the end
of the occlusion period, the clamp was released, and
reperfusion was enabled. The abdominal wall was closed
primarily with 3-0 silk suture.
Prolonged ischemia group
The superior mesenteric artery was explored and ligated
(occluded) using a 3-0 silk suture. The abdominal wall
was then closed primarily with 3-0 silk suture.
Relaparotomy was performed in all groups after 12 h
following the surgical intervention. The animals were
sacrificed by cardiac puncture. Blood samples were used
for biochemical analysis. A 10 cm ileum segment was
resected for histopathological investigation. The blood
samples were put in citrated tubes, and the intestinal
tissues were fixed in a solution of 10% formaldehyde.
Plasma urea and creatinine levels were measured in order
to assess renal function, because the plasma citrulline
level is reported to increase as a result of its lack of
clearance in renal dysfunction (17, 21).
Biochemical evaluation
For the measurement of the plasma DAO level,
Rat Diamine Oxidase ELISA kit was used (Catalog no:
CSB-E12634r, Cusabio Biotech. Wuhan). For the mea-
surement of plasma citrulline level, Rat Citrulline ELISA
kit was used (Catalog no: CSB-E13414r, Cusabio Bio-
tech. Wuhan). Plasma DAO and citrulline levels were
measured with a spectrophotometric method.
Histopathological investigation
The ileum was embedded in paraffin. Tissue sections
of 5 mm thickness were stained with hematoxylin-eosin
(H-E). Morphological changes were evaluated by using
a scoring system as Grade 1: normal appearance of
intestinal tissue, Grade 2: minimal hydropic degeneration
in surface epithelium, Grade 3: minimal necrosis of
the surface epithelium at the tip of the villus, Grade 4:
necrosis at the tip of the villi, Grade 5: full thickness
mucosal necrosis, and Grade 6: transmural necrosis (22).
Statistical analysis
Statistical analysis was done using SPSS 17.0 statistical
package. Results are reported as mean9standard devia-
tion (SD). Kruskal Wallis test was used for comparison
of all three groups. The binary comparison of the groups
was performed using Mann Whitney U test. Statistically
significance was considered as pB0.05.
Results
During the experiment no mortality was observed in
any of the groups. Blood urea and creatinine levels were
normal in all groups. Changes in the plasma citrulline
level were evaluated making sure that there is no change
resulting from renal impairment (Table 1).
Mean plasma DAO level was 0.7790.18 mIU/mL in
the control group, 3.1590.42 mIU/mL in the short-term
ischemia group, and 3.9290.55 mIU/mL in the pro-
longed ischemia group. The difference of the mean
Table 1. Plasma urea, creatinine, DAO (diamine oxidase), and citrulline levels in groups and the comparisons among the groups
Control Short-term ischemia Prolonged ischemia p
Urea (mmol/L) 13.8992.20 15.8891.73 15.2292.32 0.22
Creatinine (mmol/L) 47.2892.28 46.5196.10 43.4697.62 0.47
DAO (IU/L) 0.7790.18 3.1590.42 3.9290.55 0.0028
Citrulline (mmol/L) 53.0094.20 23.8594.52 18.4292.69 0.0037
Histopathologic score 1.7190.75 3.5790.97 5.0090.81 0.001
Mean9standard deviation.
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plasma DAO levels among the groups was statistically
significant (p0.0028). Binary comparisons also revealed
the significance of the differences between the control
group and each of the ischemia groups (p0.002) as well
as between the two ischemia groups (p0.011). Plasma
DAO increased to a higher level in the rats subjected to
the longer duration of AMI.
Mean plasma citrulline values were 53.0094.20 mmol/
L in the control group, 23.8594.52 mmol/L in the short-
term group, and 18.4292.69 mmol/L in the prolonged
ischemia group. The differences among the groups were
statistically significant (p0.0037). The mean plasma
citrulline values were also significantly different between
pairs of groups: controlshort-term groups (p0.002),
controlprolonged ischemia groups (p0.002), and
short-termprolonged ischemia groups (p0.021). The
longer the duration of AMI, the greater the decrease in
plasma citrulline level.
Histopathological evaluation
Intestinal ischemia was observed macroscopically only in
the prolonged ischemia group. In the short-term ischemia
group, the microscopic evaluation of the ischemia revealed
that Grade 2, 3, 4, and 5 had progressed in 1, 2, 3, and 1
subjects, respectively (Fig. 1a, b). The prolonged ischemia
group sustained more severe damage as Grade 4, 5, and 6
in 2, 3, and 2 subjects (Fig. 2a, b). There was a significant
difference among the three groups (p0.001) (Table 1).
The binary comparison of the groups showed significant
differences [controlshort-term groups (p0.006), con-
trolprolonged ischemia groups (p0.001), and short-
termprolonged ischemia groups (p0.017)].
Discussion
Mesenteric ischemia causes a hypoxic cell degeneration
process in intestinal epithelial cells (23). This process
disrupts the mucosal barrier and allows the entry of
digestive enzymes into the intestinal wall, leading to
autodigestion of the intestinal structure (24). In the case
of reperfusion after mesenteric ischemia, intestinal da-
mage is known to be caused by more than the ischemia
alone (25). Various factors (essentially reactive oxygen
species and activated neutrophils) during the reperfusion
contribute to the intestinal injury (26). In our study,
the experimental models of the short-term ischemia
group and the prolonged ischemia group are different.
However, the expected effect of the short ischemia is
similar because the short time ischemia (15 min) causes
slight intestinal injury that is not altered but is worsened
insignificantly by reperfusion (2325). This slight intest-
inal damage is sufficient for our comparison.
Many factors affect prognosis in AMI and increase
morbidity and mortality, including the duration of ische-
mia, presence of shockor sepsis, fluid-electrolyte disorders,
old age, cardiac, renal or respiratory diseases, and diabetes
mellitus. Prognosis is also affected by generalized perito-
nitis, length of the remnant intestine, presence of colonic
ischemia and resection, duration of operation and whether
reoperation was conducted or not (13, 27). Due to all
these factors, the mortality rate from AMI has been
reported to be very high (3).
Early diagnosis and treatment of AMI are the most
important factors in prognosis. For this reason, many
tests were investigated for the diagnosis of the AMI.
Some of the parameters are white blood cell count in
blood, AST, ALT, LDH, ALP, CRP, CK-MB, D-dimer,
troponin I, a-glutathione S-transferase, lactate, procalci-
tonin, and phosphorus levels in plasma (610, 28).
Presently, angiography appears to have the highest
sensitivity. However, it is not widely used because of its
invasive nature and the difficulty of defining its indication
early in the course of AMI. Therefore, many experi-
mental and clinical studies are performed in search
of a highly sensitive and non-invasive test for the early
diagnosis of AMI. Plasma DAO level has been suggested
to be one of the potential early markers which may be
useful in the diagnosis of AMI (14, 15). Plasma DAO
level is also reported to increase due to the intestinal
Fig. 1. Morphological changes of the intestine in the short-term ischemia group. Panel a demonstrates the score Grade 3
(*: minimal necrosis of the surface epithelium at the tip of the villus). Panel b shows the score Grade 4 with (#) necrosis at the tip
of the villi (H-E, 200).
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inflammation, ischemia, or alteration of the intestinal
mucosal integrity (1115, 29). Wollin et al. reported that
an experimental mesenteric ischemia for an hour caused
the DAO level to decrease in the intestinal mucosa, and to
increase in the intestinal lumen, mesenteric lymph nodes,
and plasma (29). Bragg et al. reported that the increase of
the DAO level in the intestinal lumen correlates with the
duration of mesenteric ischemia (14). Currently, DAO
measurement is frequently used in experimental studies as
an extra supporting marker of intestinal damage with a
specificity of 100%, accuracy of 95%, and sensitivity of
94% (16, 3032). Tsunooka et al. analyzed the coronary
bypass grafting of patients in whom cardiopulmonary
bypass was either performed or not performed (33). They
observed high plasma DAO levels in relation to the
cardiopulmonary bypass, suggesting intestinal ischemia
and damage progression. In our study, we found a 45
fold increase in the DAO level in the plasma of the
rats with AMI compared to the control rats. Moreover,
the plasma DAO level was significantly higher in the
prolonged AMI group compared with the short-term
AMI group. Our data demonstrate a strong association
between the duration of the intestinal ischemia, the rise
in plasma DAO level, and the severity of tissue damage.
In our study, we also addressed the relation between
the plasma citrulline level and acute intestinal ischemia,
about which we had found no published reports. Citrul-
line is an amino acid synthesized from glutamate in
enterocytes and metabolized in the renal pathways.
Therefore, the plasma citrulline level is expected to
increase with renal dysfunction (17, 21). However, the
plasma citrulline level has been shown to decrease
secondary to reduction of intestinal functional capacity
and impairment of the mucosal barrier (19, 20, 34, 35).
The plasma citrulline level decreases significantly in
patients with short bowel syndrome or due to massive
resections of the intestine (18, 34, 35). Jiang et al.
reported that efficiency of the rehabilitation treat-
ment for short bowel syndrome could be evaluated by
monitoring the change in plasma citrulline level (35).
An increase in plasma citrulline level is suggested to be
a marker of adequate intestinal length and absorption
surface area (35). Also, in intestinal transplantation
patients, the plasma citrulline level was found to de-
crease more during acute rejection compared to patients
without rejection (36, 37). In another study, a high dose
of chemotherapy was reported to decrease the plasma
citrulline level as a consequence of the impairment of the
intestinal mucosal barrier (20). In two other studies,
intestinal mucosal damage was investigated by comparing
plasma citrulline levels in patients with pelvic malignancy
before and after radiotherapy. It was found that the
plasma citrulline level decreased significantly following
radiotherapy (38, 39). Moreover, plasma citrulline levels
have been shown to decrease significantly, suggesting
intestinal damage in patients secondary to pancreatitis
or burns, and in patients in intensive care unit (ICU)
(40, 41). Piton et al. detected low plasma citrulline levels
in 44% of ICU patients and stated that the plasma
citrulline measurement could be a sensitive marker for the
functional enterocyte mass (42). Noordally et al. also
studied intestinal dysfunction in ICU patients and found
that among several parameters (SOFA-APACHE scores,
CRP, pre-albumin, albumin, citrulline, inotrophic agents,
and renal dysfunction) only low plasma citrulline level
correlated well with intestinal dysfunction (43). As a
different perspective, Yi et al. reported that exogenously
administered L-citrulline exhibits gastric protection by
the inhibition of neutrophil infiltration, which might be
related in prevention of the increase in iNOS activity in
an experimental gastric ischemia reperfusion study (44).
A plasma citrulline level below 27 mmol/L is thought to
suggest intestinal pathology, and a level below 15 mmol/L
is accepted as a marker of severe intestinal damage
(18, 36, 39, 43). These reports suggest that the plasma
citrulline level may be useful in the early detection of
intestinal damage.
In our study, the plasma citrulline levels were signifi-
cantly decreased in intestinal ischemic rats. Furthermore,
Fig. 2. Morphological changes of the intestine in the prolonged ischemia group. Panel a demonstrates the score Grade 5 with
full thickness mucosal necrosis. Panel b shows the score Grade 6 with transmural necrosis (H-E, 200).
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the plasma citrulline levels decreased more with prolon-
gation of ischemia and severity of the intestinal damage.
Conclusion
The plasma DAO level increases and the plasma citrulline
level decreases in AMI. Prolonged intestinal ischemia
causes a greater increase in the plasma DAO level and a
larger decrease in the plasma citrulline level. Therefore,
a combination of the plasma DAO and citrulline levels
seems to be a good marker for the early detection of
AMI. However, extensive clinical studies are needed to
corroborate these findings in humans.
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